ALKERMES | ALKS - Ticaret Alacaklılar





Ticaret Alacaklılar Değişiklik Tarih
AbbVie USD 33.3B 29.71B 2026-06
Acadia Pharmaceuticals USD 16.33M 28.24M 2026-09
ALKERMES USD 107.69M 35.17M 2026-09
Amgen USD 20.83B 17.97B 2026-09
Biogen USD 430.3M 26.4M 2026-09
BioMarin Pharmaceutical USD 946.11M 32.44M 2026-09
Bristol-Myers Squibb USD 4.63B 470M 2026-09
Coherus Biosciences USD 13.17M 1.69M 2026-06
Eli Lilly USD 5.79B 319M 2026-09
Gilead Sciences USD 934M 260M 2026-09
Heron Therapeutics USD 8.38M 3.27M 2026-09
Ionis Pharmaceuticals USD 27.11M 20.59M 2026-09
J&J USD 9.32B 94M 2026-09
Malin Corporation EUR 700K 200K 2024-12
Merck USD 5.03B 1.2B 2026-09
Minerva Neurosciences USD 640K 305K 2025-12
Nektar Therapeutics USD 10.03M 744K 2026-03
Neurocrine Biosciences USD 754.1M 612.1M 2026-09
Otsuka Holdings JPY 199.81B 16.83B 2026-09
Ovoca Bio EUR 1.3M 1.11M 2025-12
Pfizer USD 4.07B 511M 2026-09
Regeneron Pharmaceuticals USD 1.14B 19M 2026-09
Vertex Pharmaceuticals USD 3.71B 99.2M 2026-09